Back to search

Article

Increased seroprevalence and improved antibody responses following third primary SARS-CoV-2 immunisation: an update from the COV-AD study

2022-04-05

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>Patients with primary and secondary antibody deficiency are vulnerable to COVID-19 and demonstrate diminished responses following two-dose SARS-CoV-2 vaccine schedules. Third primary vaccinations have been deployed to enhance their humoral and cellular immunity.<bold> </bold><bold>Objectives</bold>To determine the immunogenicity of the third primary SARS-CoV-2 imm...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
257853bd-47a5-5484-b97a-a81695a91d41
DOI
10.21203/rs.3.rs-1489715/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Increased seroprevalence and improved antibody responses following third primary SARS-CoV-2 immunisation: an update from the COV-AD studyDOI 10.21203/rs.3.rs-1489715/v1
SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings From The COV-AD StudySemantic proximity
Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccinationSemantic proximity
Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccinesSemantic proximity
Dynamic Antibody Response in SARS-CoV-2 Infected Patients and COVID-19 Vaccine Recipients, and Vaccine Effectiveness in Comorbid and Multimorbid Patients​Semantic proximity
The Impact of SARS-CoV-2 Vaccination and Infection on Neutralising Antibodies: A Nation-Wide Cross-Sectional AnalysisSemantic proximity
Immunogenicity and Safety of COVID-19 Booster Vaccination: A Real-World Clinical Trial to Identify the Best Vaccination StratagySemantic proximity
SARS-CoV-2 evolution and patient immunological history shape the breadth and potency of antibody-mediated immunitySemantic proximity
Determinants of antibody responses to two doses of ChAdOx1 nCoV-19 or BNT162b2 and a subsequent booster dose of BNT162b2 or mRNA-1273: population-based cohort study (COVIDENCE UK)Semantic proximity
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variantsSemantic proximity
A review of leading COVID-19 vaccines, the quest for immune protection, and its key challenges. Part 3: Covid-19 vaccines – Key challenges and translational scienceSemantic proximity
Determinants of Antibody Responses to Two Doses of ChAdOx1 nCoV-19 or Bnt162b2 and a Subsequent Booster Dose of BNT162b2 or mRNA-1273: Population-Based Cohort Study (COVIDENCE UK)Semantic proximity
Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals.Semantic proximity
Select a neighboring publication to make it the new centre.